Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. use of histological scores
Geboes, K.; Desreumaux, P.; Jouret, A.; Ectors, N.; Rutgeerts, P.; Colombel, J.F.
Gastroenterologie Clinique et Biologique 23(10): 1062-1073
1999
ISSN/ISBN: 0399-8320 PMID: 10592879 Document Number: 504765
Document emailed within 1 workday
Related Documents
Sánchez Lombraña, J.; Palacio, M.A.; Carbajal, C.; Vivas, S.; Pérez, R.; Rodrigo, L. 1997: Biological markers of activity in chronic inflammatory bowel disease Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 89(11): 855-858Héuterne, X. 2014: Circumstances of diagnosis and differential diagnosis of chronic inflammatory bowel disease La Revue du Praticien 64(9): 1222-1225
Limberg, B. 1999: Diagnosis of chronic inflammatory bowel disease by ultrasonography Zeitschrift für Gastroenterologie 37(6): 495-508
Seibold, F.; Wagner, A.C.; Göke, B. 2000: Drug treatment of chronic inflammatory bowel diseases: current status and prospects Schweizerische Medizinische Wochenschrift 130(7): 222-232
Taylor, S.; Lobo, A.J. 2016: Diagnosis and treatment of inflammatory bowel disease Practitioner 260(1795): 19-23
Frenzer, A. 2011: Inflammatory bowel disease: diagnosis and treatment in general practice Revue Medicale Suisse 7(279): 250-251
Kolacek, S. 2002: Role of enteral nutrition in the treatment of chronic inflammatory bowel disease Medicinski Arhiv 56(1 Suppl 1: 21-22
Cekic, C.; Arabul, M.; Alper, E.; Pakoz, Z.B.K.; Saritas, E.; Yuksel; Ünsal, B. 2014: Evaluation of the relationship between serum ghrelin, C-reactive protein and interleukin-6 levels, and disease activity in inflammatory bowel diseases Hepato-Gastroenterology 61(133): 1196-1200
Rasmussen, S.N.; Bondesen, S.; Nielsen, O.H.; Binder, V.; Hansen, S.H.; Hvidberg, E. 1985: 5-amino-salicylic acid. a review of a new treatment of chronic inflammatory bowel disease Ugeskrift for Laeger 147(36): 2811-2815
Swaak, A. 2006: Anemia of chronic disease in patients with rheumatoid arthritis: aspects of prevalence, outcome, diagnosis, and the effect of treatment on disease activity Journal of Rheumatology 33(8): 1467-1468
Griffin, M.G.; Miner, P.B. 1995: Conventional drug therapy in inflammatory bowel disease Gastroenterology Clinics of North America 24(3): 509-521
García López, S. 2008: Inflammatory bowel disease. If a patient with Crohn's disease remains in remission for 4 years with azathioprine (or mercaptopurine), should the drug be withdrawn? Gastroenterologia y Hepatologia 31(10): 704-705
Becker, K.; Niederau, C.; Frieling, T. 1999: Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease Zeitschrift für Gastroenterologie 37(7): 597-605
Hylander, E.; Jarnum, S.; Frandsen, I. 1979: Urolithiasis and hyperoxaluria in chronic inflammatory bowel disease Scandinavian Journal of Gastroenterology 14(4): 475-479
Faurschou, P.; Maltbaek, N.; Skov, B.G. 2005: Pulmonary diseases and chronic inflammatory bowel disease Ugeskrift for Laeger 167(1): 38-40
Das, S.K.; Montgomery, R.D. 1978: Chronic inflammatory bowel disease in Asian immigrants Practitioner 221(1325): 747-749
Bøggild, H.; Tüchsen, F.; Orhede, E. 1998: Occupational and chronic inflammatory bowel disease in Denmark Ugeskrift for Laeger 160(10): 1470-1475
García-Planella, E.; Marín, L.; Domènech, E.; Bernal, I.; Mañosa, Míriam.; Zabana, Y.; Gassull, M.A. 2007: Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease Medicina Clinica 128(2): 45-48
Teisberg, P.; Gjone, E. 1975: Humoral immune system activity in inflammatory bowel disease Scandinavian Journal of Gastroenterology 10(5): 545-549
Packer, N.; Hoffman-Goetz, L.; Ward, G. 2010: Does physical activity affect quality of life, disease symptoms and immune measures in patients with inflammatory bowel disease? a systematic review Journal of Sports Medicine and Physical Fitness 50(1): 1-18